George Gauthier
Corporate Officer/Principal bei IGM BIOSCIENCES, INC.
Vermögen: 303 261 $ am 30.04.2024
Profil
George A.
Gauthier is currently the Chief Commercial Officer at IGM Biosciences, Inc. Previously, he worked as the Vice President-Global Product Strategy at Genentech, Inc. He received his undergraduate degree from Michigan State University and his MBA from Kellogg School of Management.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
IGM BIOSCIENCES, INC.
0,12% | 29.11.2023 | 39 642 ( 0,12% ) | 303 261 $ | 30.04.2024 |
Aktive Positionen von George Gauthier
| Unternehmen | Position | Beginn |
|---|---|---|
| IGM BIOSCIENCES, INC. | Corporate Officer/Principal | 12.04.2021 |
Ehemalige bekannte Positionen von George Gauthier
| Unternehmen | Position | Ende |
|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01.04.2021 |
Ausbildung von George Gauthier
| Michigan State University | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| IGM BIOSCIENCES, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
